Supplementary Figure S21 shows the association between baseline (apheresis day) systemic short-chain fatty acid levels and treatment response in multiple myeloma patients. This figure analyzes serum SCFA levels at 100 and 180 days post–CAR T-cell infusion, comparing patients who achieved complete response to those who did not.
Uribe‐Herranz et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: